Clinical Trials Browser

Phase 1 × Completed × naquotinib × Clear all

NCT02113813 2024-11-14

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung